This cohort study examines the safety and efficacy of rituximab for patients with pempigus foliaceus.
No takes yet. Share an insight, caveat, or question.
Tedbirt et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: